Wei Wu He
Chief Executive Officer at CASI PHARMACEUTICALS, INC.
Profile
Wei Wu He founded Chongqing TCR CURE Biopharma Technology Co., Ltd in 2016, Beijing TCRcure Biotechnology Co., Ltd.
in 2016, Intradigm Corp.
in 2000, where he is working as Director from 2000, Emerging Technology Partners LLC in 2000, where he is working as General Partner from 2000, OriGene Technologies, Inc. in 1995, where he is working as Chairman from 2019, and Genetron Holdings Ltd.
in 2015, where he worked as Chairman.
Dr. He also currently works at CASI Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2019, Human Longevity, Inc., as Executive Chairman from 2019, Beijing Genetron Biotechnology Co. Ltd., as Chairman, Beijing Genetron Health Gene Technology Co., Ltd., as Chairman, MithraGen, Inc., as Director, J.
Craig Venter Institute, Inc., as Trustee, and DoctorsForMe, Inc., as Chief Executive & Financial Officer.
Dr. He also formerly worked at Cytomyx Holdings Plc, as Chairman & Chief Executive Officer, CASI Pharmaceuticals, Inc., as Executive Chairman from 2018 to 2019, Amnis Corp., as Director, and Human Genome Sciences, Inc., as President.
Dr. He received his doctorate degree from Baylor College of Medicine and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Wei Wu He active positions
| Companies | Position | Start |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Chief Executive Officer | 01/04/2019 |
Emerging Technology Partners LLC
 Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California. | Founder | 31/12/1999 |
Beijing Genetron Biotechnology Co. Ltd.
 Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Genetron Biotechnology Co. Ltd. provides healthcare solutions. It offers Cancer Genetic Testing, DNA Methylation Sequencing, RNA Sequencing, Whole-Exome Sequencing and Glioma Panel. The company was founded in December 2013 by Si-Zhen Wang and Hai Yan and is headquartered in Beijing, China. | Chairman | - |
J. Craig Venter Institute, Inc.
 J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Director/Board Member | - |
DoctorsForMe, Inc.
 DoctorsForMe, Inc. Medical/Nursing ServicesHealth Services DoctorsForMe, Inc. provides health care services. The company is headquartered in Redwood City, CA. | Chief Executive Officer | - |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Chairman | - |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Chairman | 30/06/2019 |
MithraGen, Inc.
 MithraGen, Inc. Pharmaceuticals: MajorHealth Technology MithraGen, Inc. develops immunotherapies for the treatment and prevention of cancer and infectious diseases. The company was founded in 2000 and is headquartered in Houston, TX. | Director/Board Member | 13/08/2009 |
OriGene Technologies, Inc.
 OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Founder | 31/12/1994 |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Wei Wu He
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░ | - |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Wei Wu He
| Baylor College of Medicine | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 16 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Amnis Corp. provides cell imaging and instrument development, manufacturing and marketing services. The Company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs. The company was founded by David A. Basiji, William E. Ortyn and Harold H. Kawaguchi in 1999 and is headquartered in Seattle, WA. | Health Technology |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Cytomyx Holdings Plc
 Cytomyx Holdings Plc Pharmaceuticals: MajorHealth Technology Cytomyx Holdings Plc provided drug discovery products and services. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Emerging Technology Partners LLC
Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California. | Finance |
MithraGen, Inc.
MithraGen, Inc. Pharmaceuticals: MajorHealth Technology MithraGen, Inc. develops immunotherapies for the treatment and prevention of cancer and infectious diseases. The company was founded in 2000 and is headquartered in Houston, TX. | Health Technology |
OriGene Technologies, Inc.
OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD. | Commercial Services |
J. Craig Venter Institute, Inc.
J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Commercial Services |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Health Technology |
Beijing Genetron Biotechnology Co. Ltd.
Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Genetron Biotechnology Co. Ltd. provides healthcare solutions. It offers Cancer Genetic Testing, DNA Methylation Sequencing, RNA Sequencing, Whole-Exome Sequencing and Glioma Panel. The company was founded in December 2013 by Si-Zhen Wang and Hai Yan and is headquartered in Beijing, China. | Health Technology |
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Technology Services |
DoctorsForMe, Inc.
DoctorsForMe, Inc. Medical/Nursing ServicesHealth Services DoctorsForMe, Inc. provides health care services. The company is headquartered in Redwood City, CA. | Health Services |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
Beijing TCRcure Biotechnology Co., Ltd.
 Beijing TCRcure Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing TCRcure Biotechnology Co., Ltd. develops and markets tumor immune cell therapy technology. The company is based in Beijing, China. The Chinese company was founded in 2016 by Su Frank, Li Qi-Jing, Wang Pin, Wei-Wu He. The CEO is Su Zhenpo. | Commercial Services |
- Stock Market
- Insiders
- Wei Wu He
